Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetrodotoxin-sensitive voltage-gated sodium channels (TTX-s Nav channels) are a functional group of ion channels comprising the isoforms Nav1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.6, and Nav1.7 (Catterall et al., 2005, Pharmacological Reviews). These channels are characterized by their high affinity for tetrodotoxin (TTX), which blocks the ion-conducting pore and prevents the influx of sodium ions necessary for action potential generation (Narahashi, 2008, Proceedings of the Japan Academy, Series B). They are widely expressed in the central and peripheral nervous systems, as well as skeletal muscle, where they mediate rapid electrical signaling (Goldin, 2001, Annual Review of Physiology). Dysfunction of TTX-s Nav channels is linked to numerous diseases, including various forms of epilepsy, chronic pain syndromes like erythromelalgia, and neuromuscular disorders such as periodic paralysis (Meisler & Kearney, 2005, Journal of Clinical Investigation; Dib-Hajj et al., 2013, Nature Reviews Neuroscience). Pharmacologically, these channels are the primary targets for local anesthetics, anticonvulsants, and antiarrhythmics, which typically act by stabilizing the inactivated state of the channel or physically blocking the pore (Catterall, 2012, Cold Spring Harbor Perspectives in Biology). Selective targeting of specific TTX-s isoforms remains a major goal in drug development to minimize off-target effects in the heart or central nervous system.
Drugs targeting TTX-s Nav channels typically act as pore blockers or gating modifiers that stabilize the non-conducting inactivated state, thereby reducing the probability of channel opening and suppressing high-frequency firing (Catterall, 2012, Cold Spring Harbor Perspectives in Biology).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetrodotoxin-sensitive voltage-gated sodium channel (TTX-s Nav channel) (TTX-s Nav channel).